Archives     Advertise     Editorial Calendar     Subscribe     Contact Us    



Study Highlights Higher Death Rate for Young People Experiencing an Incident Episode of Psychosis


 

A study published last month in the journal Schizophrenia Bulletin found the death rate in young people during the year following a first episode psychosis incidence was much higher than anticipated.

Analyzing claims data on approximately 5,000 young people ages 16-30 with commercial insurance who had received a first observed psychosis diagnosis, researchers from the National Institute of Mental Health (NIMH) found the group had a mortality rate of at least 24 times higher than the same group in the general population in the 12 months following the index psychotic episode.


Michael Schoenbaum, PhD

With abundant clinical evidence from the United States and other countries showing a correlation between mental illness and decreased life expectancy, the NIMH research team expected there would be elevated mortality for this group but were still surprised by the findings. "I wasn't surprised by the direction of the effect. I was surprised and shocked by the scale of the effect," said Michael Schoenbaum, PhD, senior advisor for Mental Health Services, Epidemiology and Economics for NIMH who led the research project.

He added, "We were so shocked when we first did this analysis that we bent over backwards to check it and make sure we hadn't used the data wrong and made a mistake."

After recalculating, the team concluded they hadn't missed the mark ... and, in fact, reported the figures using the most conservative assumptions. "To find a group in the U.S. general population with mortality as high as our conservative estimate for these young people, you have to look at Americans over age 70," said Schoenbaum. "The upper end estimate is more than a 7 percent mortality rate in a year. In the general U.S. population, you wouldn't expect to see that rate until people are in their 80s."

In addition to mortality, the study also looked at the healthcare treatment those ages 16-30 received in the 12 months following the initial psychosis diagnosis. That analysis uncovered the group had low rates of medical oversight and only modest involvement with psychosocial treatment providers. According to the report, "In the year after index, 61 percent of the cohort filled no antipsychotic prescriptions and 41 percent received no individual psychotherapy. Nearly two-thirds (62 percent) of the cohort had at least one hospitalization and/or one emergency department visit during the initial year of care."

Schoenbaum said the NIMH has made it a strategic priority to not only discover new treatment options for those with a diagnosed mental illness but to also develop and test better ways to deliver existing treatments.

"This is a devastating thing to happen in people's lives," he noted. "We've had data for a long time that suggests historically there has been a long gap in time between when a person experiences psychosis for the first time and when they receive meaningful care."

This new analysis, he said, helps confirm that suggestion and shows there is much room for improvement. The study, which looked at 2008-2009 commercial payer data, was made possible through a multi-payer claims database built by the Department of Health and Human Services using funds from the stimulus package following the financial crisis.

"That dataset did two things we couldn't easily do before this," explained Schoenbaum. "First, it was a really large sample."

He said having access to this commercial payer information was critical since most young people in the United States have commercial insurance ... if they have coverage ... at the time of symptom onset. While Schoenbaum said a limitation of the study was that the team couldn't definitively say it was each individual's first episode of psychosis without having lifelong data, they did single out only those young people who had no sign of psychosis in the 12 months prior to the documented episode.

"The second innovation in this dataset is that it also contained information on mortality," he continued. "In this country, it is relatively rare to link information on people's health and healthcare on the one hand with death and mortality on the other."

There are, of course, exceptions. Schoenbaum said there is really good mortality data available for cancer and cardiovascular surgery. "But there is no place in mental health where we do that right now," he noted. "You have to know there's a problem before you can fix it. If we can't study patterns of mortality, we don't know if there's a problem and what kind of problem it might be."

Going forward, Schoenbaum said he would like to see if their findings are replicated in other U.S. samples and to have access to more specific mortality data. The database used listed all cause death without specifying if mortality was a result of suicide, homicide, accident, or other. "It would be really valuable to not just know that they died but how they died."

He also said it's important to implement the clinical practice guidelines that already exist more consistently and then measure the impact on mortality. Despite being identified with early psychosis, Schoenbaum said the analysis highlighted the next critical step of effectively connecting these patients to models of care didn't routinely happen.

"This is a highly vulnerable population. We just didn't realize how vulnerable," Schoenbaum said of the study's results. "We want to connect them to effective services. One hope is that people recognize that these individuals aren't just at risk of suffering ... their lives are at stake."

On the positive side, he continued, "The relatively low levels of care that we observed here underscore the potential value of the new models for treating first episode psychosis, specifically what's called coordinated specialty care."

Congress has earmarked 10 percent of SAMHSA mental health block grant funding go to states for coordinated specialty care programs for first episode psychosis. "By 2018, all states are expected to have at least one such program, and some states will have multiple programs," Schoenbaum said, adding such programs are measurement-based and are engineered to analyze results and make adjustments as needed.

Schoenbaum's other hope is that the study will help launch larger conversations about mental health and mortality. "Together with the national increase in suicide rates and the national epidemic of deaths from opioid overdose, I think this paper underscores the importance of tracking mortality as an outcome for people with behavioral health problems," he said.

"In the meantime, this study is a wake-up call telling us that young people experiencing psychosis need intensive, integrated clinical and psychosocial supports," Schoenbaum concluded.

RELATED LINKS:
NIMH
Paper Abstract in Schizophrenia Bulletin
RAISE: Recovery After Initial Schizophrenia Episode

 
Share:

Related Articles:


Recent Articles

Increasing Number Of Tennesseans Dying From Drug Overdoses

Tennessee Department of Health data show 1,631 Tennesseans died from drug overdoses in 2016, the highest annual number of such deaths recorded in state history. This is an increase from the 1,451 overdose deaths recorded among Tennessee residents in 2015.

Read More

AMA Urges Congress to Take Swift Action to Retain DACA Program Protections

The American Medical Association sent a letter to Congress on Sept. 5 outlining why DACA is an American healthcare issue and urging legislators to take prompt action to ensure individuals with Deferred Action for Childhood Arrivals status are able to remain in the United States.

Read More

New Antiviral Drug Inhibits Epidemic SARS, MERS & More

A multi-institutional team of researchers has found a new antiviral drug candidate that could treat or prevent a number of potential pandemic outbreaks.

Read More

Disaster Preparedness: Are We Ready?

In a world of ever-evolving threats, the officials responsible for a community's health and safety must constantly update, evaluate, prepare and communicate their preparedness plan.

Read More

Addressing Opioid Addiction in America

Even as the AMA works with physicians and other providers to address opioid addiction, the national epidemic continues to evolve.

Read More

Moving Forward on Health Reform

THA's Craig Becker shares the hospital perspective on healthcare reform and what's needed to maintain access to care across Tennessee.

Read More

MGMA Releases 2017 Regulatory Burden Survey: MIPS Tops the List

The results of the Medical Group Management Association (MGMA) 2017 Regulatory Burden Survey reveal there is no shortage of opportunity to reduce regulatory burdens on physician practices.

Read More

In Case of Emergency

On Sept. 8, 2016 the final rule Emergency Preparedness Requirements for Medicare and Medicaid Participating Providers and Suppliers was published in the Federal Register. By Nov. 16, 2017, providers and suppliers must be in compliance.

Read More

Innovative Meharry Program Helps Mothers with Opioid Addiction

The Rainbow Program at Meharry offers pregnant and postpartum women with substance abuse disorders new hope.

Read More

The Osher Center: Healing Mind, Body & Spirit

Multi-faceted approach to pain management blends old and new therapies at The Osher Center for Integrative Medicine at Vanderbilt

Read More

Email Print
 
 

 

 


Tags:
Coordinated Specialty Care, First Episode Psychosis, Mental Health, Michael Schoenbaum, Mortality Rates, National Institute of Mental Health (NIMH), National Institutes of Health, NIH, Schizophrenia
Powered by Bondware
News Publishing Software

The browser you are using is outdated!

You may not be getting all you can out of your browsing experience
and may be open to security risks!

Consider upgrading to the latest version of your browser or choose on below: